## DHI: D.R. Horton, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 1.21 indicates fundamental undervaluation.

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($147.63)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Stance Capital LLC Has $2.02 Million Position in D.R. Horton, Inc. $DHI**
- Source: MarketBeat | 20251214T125011 | Neutral | Relevance: 100%
- Stance Capital LLC significantly reduced its stake in D.R. Horton, Inc. ($DHI) by 45.6% during the second quarter, bringing its total holdings to $2.02 million. Despite this reduction, other institutional investors like Norges Bank and Berkshire Hathaway Inc. acquired substantial new positions in the construction company. Analysts currently rate D.R. Horton with a "Hold" consensus and a target price of $161.08, while the company recently increased its quarterly dividend.

**2. DR Horton (DHI) Jumps 17% After Earnings Beat**
- Source: MSN | 20251216T080743 | Bullish | Relevance: 100%
- This article reports that DR Horton (DHI) stock experienced a significant 17% jump following an earnings beat. Further details about the specific earnings figures and factors contributing to the beat are needed to provide a more comprehensive summary.

**3. Provident Investment Management Inc. Has $461,000 Position in D.R. Horton, Inc. $DHI**
- Source: MarketBeat | 20251214T132356 | Neutral | Relevance: 100%
- Provident Investment Management Inc. reduced its stake in D.R. Horton, Inc. (NYSE:DHI) by 64.9% in the second quarter, now holding 3,579 shares valued at $461,000. Despite this, other institutional investors increased their positions in the homebuilding company. D.R. Horton recently reported Q4 earnings that missed analyst estimates but increased its quarterly dividend to $0.45, yielding 1.1%.

**4. Brave Warrior Advisors LLC Lowers Stock Position in D.R. Horton, Inc. $DHI**
- Source: MarketBeat | 20251213T102930 | Neutral | Relevance: 100%
- Brave Warrior Advisors LLC has reduced its stock holdings in D.R. Horton, Inc. (NYSE:DHI) by 1.6% in the second quarter, selling 18,725 shares. Despite this reduction, D.R. Horton remains a significant portion of Brave Warrior Advisors' portfolio, ranking as its 15th largest holding. The article also notes other institutional investor activities, analyst ratings, and the company's recent financial performance, including a dividend increase.

**5. Luxor Capital Group LP Makes New $1.01 Million Investment in D.R. Horton, Inc. $DHI**
- Source: MarketBeat | 20251213T100737 | Somewhat-Bullish | Relevance: 100%
- Luxor Capital Group LP has made a new investment of $1.01 million in D.R. Horton, Inc. (NYSE: DHI) by purchasing 7,825 shares during the second quarter. Despite missing recent EPS expectations, D.R. Horton increased its quarterly dividend to $0.45, and institutional investors now own over 90% of the company's stock. Analysts currently hold a "Hold" rating on DHI, with an average target price of $161.08.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Barclays | $132 | $110 | +20% |
| 2025-12-08 | Wells Fargo | $180 | $190 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Barclays | main | Equal-Weight |
| 2025-12-08 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 19 ($0.00M) |
| Sells | 10 ($0.34M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.3% (-0.9%)
- Capital World Invest: 10.4% (+159.8%)
- Blackrock Inc.: 10.1% (+1.1%)
- JPMORGAN CHASE & CO: 7.2% (+96.2%)
- State Street Corpora: 4.2% (-2.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +5.6% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.21 suggests fair value with growth premium. Forward P/E 11.7x attractive for 18% earnings growth. Balance sheet: strong liquidity (17.4x), low leverage (D/E 0.44), $2.4B free cash flow. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $45.7B |
| Beta | 1.38 |
| 52W Range | $110.44 - $184.55 |
| Short Interest | 5.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.21 |
| Forward P/E | 11.7 |
| Current P/E | 13.7 |
| YoY Growth | 17.8% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -2.3% to 3.3% (+5.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.7pp (needs >4.0% for momentum thesis). MRS_5 at 2.8% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 55. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.28% (CS: 62) | Neutral |
| RSI_14 | 54.6 | Neutral |
| MACD Histogram | 0.34 | Bullish |
| vs SMA20 | 1.030x | Above |
| vs SMA50 | 1.029x | Above |
| vs SMA200 | 1.097x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $156.47
- **Stop Loss:** $147.63 (5.6% risk)
- **Target:** $174.15 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 135
- **Position Value:** $21,123.45
- **Portfolio %:** 21.12%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-20 (Est: $1.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.29 | $3.04 | -7.7% |
| 2025Q2 | $2.87 | $3.36 | +16.9% |
| 2025Q1 | $2.65 | $2.58 | -2.7% |
| 2024Q4 | $2.37 | $2.61 | +10.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*